Female Ductal Carcinoma In Situ
1 clinical trials · Condition
◉ Watch Female Ductal Carcinoma In Situ
| Record | Firm | Date |
|---|---|---|
| A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant (NCT02540330) | Atossa Therapeutics, Inc. | 2016-03-01 |
Track Female Ductal Carcinoma In Situ automatically
Every clearance here is in the API, with alerts when new ones post.